Business Context and Reporting Period
This Form 8-K was filed by Bionano Genomics, Inc. on May 3, 2020. The filing reports significant corporate governance changes, including the dismissal of the independent registered public accounting firm, the engagement of a new auditor, and changes to the Board of Directors.
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, or debt levels. However, it references historical audit reports for the fiscal years ended December 31, 2019, and 2018, which included an explanatory paragraph relating to substantial doubt about the Company's ability to continue as a going concern.
Material Changes
- Change in Auditor: The Audit Committee dismissed Deloitte & Touche LLP and engaged BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- Internal Control Weaknesses: The filing confirms material weaknesses in internal control over financial reporting as of December 31, 2019, primarily due to insufficient resources to support growth and a lack of appropriate segregation of duties. These weaknesses did not result in identified material misstatements.
- Board Composition: Junfeng Wang resigned from the Board effective May 4, 2020. Hannah Mamuszka and Yvonne Linney, Ph.D., were appointed as Class II and Class III directors, respectively, effective immediately.
Guidance, Outlook, and Risks
The filing does not provide forward-looking financial guidance or management commentary on future operations. Key risks and contingencies highlighted include:
- Going Concern: Previous audit opinions expressed substantial doubt regarding the Company's ability to continue as a going concern.
- Internal Controls: The Company is in the process of remediating material weaknesses in internal controls related to financial reporting resources and segregation of duties.
Investor Verification Checklist
- Verify the status of the Company's liquidity and capital resources given the historical "going concern" qualification.
- Review the 2019 Form 10-K for details on the specific remediation plans for internal control material weaknesses.
- Confirm the transition timeline and scope of work between the outgoing auditor (Deloitte) and the incoming auditor (BDO).
- Assess the impact of the Board changes on corporate governance and strategic direction.